These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10758791)
1. Effect of sequential estrogen/progestin treatment on biochemical vasoactive markers in postmenopausal women comparing oral and transdermal application. Seeger H; Mueck AO; Teichmann AT; Lippert TH Clin Exp Obstet Gynecol; 2000; 27(1):17-20. PubMed ID: 10758791 [TBL] [Abstract][Full Text] [Related]
2. Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest. Mueck AO; Seeger H; Lüdtke R; Gräser T; Wallwiener D Maturitas; 2001 May; 38(3):305-13. PubMed ID: 11358648 [TBL] [Abstract][Full Text] [Related]
3. [Effect of transdermal versus oral estradiol administration on the excretion of vasoactive markers in postmenopausal women]. Mueck AO; Seeger H; Lippert TH Gynakol Geburtshilfliche Rundsch; 2000; 40(2):61-7. PubMed ID: 10971087 [TBL] [Abstract][Full Text] [Related]
4. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane. Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497 [TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of vasoactive markers following estrogen replacement therapy in postmenopausal women. Mueck AO; Seeger H; Lippert C; Wallwiener D Int J Clin Pharmacol Ther; 2000 Aug; 38(8):381-6. PubMed ID: 10984011 [TBL] [Abstract][Full Text] [Related]
6. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H Menopause; 2007; 14(6):978-84. PubMed ID: 17595593 [TBL] [Abstract][Full Text] [Related]
7. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568 [TBL] [Abstract][Full Text] [Related]
8. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium. Johannisson E; Holinka CF; Arrenbrecht S Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386 [TBL] [Abstract][Full Text] [Related]
9. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate. Campagnoli C; Colombo P; De Aloysio D; Gambacciani M; Grazioli I; Nappi C; Serra GB; Genazzani AR Maturitas; 2002 Apr; 41(4):299-311. PubMed ID: 12034517 [TBL] [Abstract][Full Text] [Related]
10. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women. Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954 [TBL] [Abstract][Full Text] [Related]
11. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B; Guzic-Salobir B; Sebestjen M; Keber I Menopause; 2006; 13(4):643-50. PubMed ID: 16837886 [TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms. Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442 [TBL] [Abstract][Full Text] [Related]
13. Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens. Lahdenperä S; Puolakka J; Pyörälä T; Luotola H; Taskinen MR Atherosclerosis; 1996 May; 122(2):153-62. PubMed ID: 8769679 [TBL] [Abstract][Full Text] [Related]
14. Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2. Viinikka L; Orpana A; Puolakka J; Pyörälä T; Ylikorkala O Obstet Gynecol; 1997 Jan; 89(1):104-7. PubMed ID: 8990448 [TBL] [Abstract][Full Text] [Related]
15. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women. Mueck AO; Seeger H; Kasspohl-Butz S; Teichmann AT; Lippert TH Horm Metab Res; 1997 Feb; 29(2):80-3. PubMed ID: 9105905 [TBL] [Abstract][Full Text] [Related]
16. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids. Rozenberg S; Ylikorkala O; Arrenbrecht S Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385 [TBL] [Abstract][Full Text] [Related]